NCT01999257

Brief Summary

The investigators have developed a new website to educate persons of Ashkenazi Jewish ancestry about their increased risk for having children with certain genetic conditions, and the genetic testing the investigators offer. This study aims to pilot the website to find out whether it is effective and to learn what the investigators can improve. Participants in the study will be assigned to one of two conditions:

  1. 1.Standard in-person genetic counselling session to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. Participants will fill out two short questionnaires, one before and one after the genetic counselling session. They will then be given a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre.
  2. 2.Use of a web-based pre-test genetic counselling tool to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. They will fill out two short questionnaires, one before, and one after using the web-based tool. They will then be electronically sent a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 3, 2013

Completed
7 months until next milestone

Study Start

First participant enrolled

July 1, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

August 17, 2017

Status Verified

August 1, 2017

Enrollment Period

9 months

First QC Date

November 25, 2013

Last Update Submit

August 14, 2017

Conditions

Keywords

Genetic CounselingTechnologyAshkenazi JewishCarrier screening

Outcome Measures

Primary Outcomes (1)

  • Knowledge of Ashkenazi Jewish genetic conditions

    Evaluated by questionnaire developed specifically for this study.

    1 hour

Secondary Outcomes (3)

  • Patient anxiety

    1 hour

  • Satisfaction with web-based/in-person genetic counselling

    1 hour

  • Perceived risk of having a child with an Ashkenazi Jewish genetic condition

    1 hour

Study Arms (2)

In-person counselling

NO INTERVENTION

Similar to standard of care, wherein Ashkenazi Jewish individuals seeking carrier genetic screening meet a genetic counsellor for an in-person education and counselling session.

Online pre-test genetic education tool

ACTIVE COMPARATOR

Use of a web-based pre-test education program, wherein the information from a typical genetic counselling session for carrier screening in Ashkenazi Jewish individuals is presented.

Other: Online pre-test genetic education tool

Interventions

See Arm Descriptions above.

Online pre-test genetic education tool

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least one grandparent of Ashkenazi Jewish descent
  • Access to computer at home and computer literate

You may not qualify if:

  • Participant or participant's partner is pregnant at time of study
  • Family history of an Ashkenazi Jewish genetic condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal General Hospital (MUHC)

Montreal, Quebec, H3G 1A4, Canada

Location

MeSH Terms

Conditions

Tay-Sachs DiseaseCanavan DiseaseDysautonomia, Familial

Condition Hierarchy (Ancestors)

Gangliosidoses, GM2GangliosidosesSphingolipidosesLysosomal Storage Diseases, Nervous SystemBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLipidosesLipid Metabolism, Inborn ErrorsLysosomal Storage DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesLipid Metabolism DisordersHereditary Central Nervous System Demyelinating DiseasesLeukoencephalopathiesDemyelinating DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPrimary DysautonomiasAutonomic Nervous System DiseasesHereditary Sensory and Autonomic NeuropathiesNervous System MalformationsPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesCongenital Abnormalities

Study Officials

  • Guillaume Sillon, MSc

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Genetic counsellor

Study Record Dates

First Submitted

November 25, 2013

First Posted

December 3, 2013

Study Start

July 1, 2014

Primary Completion

April 1, 2015

Study Completion

August 1, 2017

Last Updated

August 17, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will share

Publication of study results in a peer-reviewed journal.

Locations